Northern Trust’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.7K | Sell |
46,776
-62,249
| -57% | -$74.1K | ﹤0.01% | 4212 |
|
|
2025
Q1 | $221K | Sell |
109,025
-8,298
| -7% | -$16.8K | ﹤0.01% | 3910 |
|
|
2024
Q4 | $706K | Buy |
117,323
+11,925
| +11% | +$71.8K | ﹤0.01% | 3532 |
|
|
2024
Q3 | $738K | Sell |
105,398
-8,655
| -8% | -$60.6K | ﹤0.01% | 3455 |
|
|
2024
Q2 | $662K | Buy |
114,053
+6,303
| +6% | +$36.6K | ﹤0.01% | 3402 |
|
|
2024
Q1 | $770K | Buy |
107,750
+27,601
| +34% | +$197K | ﹤0.01% | 3412 |
|
|
2023
Q4 | $394K | Buy |
80,149
+7,427
| +10% | +$36.5K | ﹤0.01% | 3622 |
|
|
2023
Q3 | $695K | Buy |
72,722
+4,044
| +6% | +$38.7K | ﹤0.01% | 3415 |
|
|
2023
Q2 | $890K | Sell |
68,678
-1,073
| -2% | -$13.9K | ﹤0.01% | 3400 |
|
|
2023
Q1 | $885K | Buy |
+69,751
| New | +$885K | ﹤0.01% | 3260 |
|